BioSig Technologies, Inc. STEX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from BioSig Technologies, Inc.’s reported figures.
Based on trailing twelve months.
The official record: BioSig Technologies, Inc.’s 10-K, filed April 15, 2025, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s free cash flow margin?
- BioSig Technologies, Inc. (STEX) reported free cash flow margin of -97,216.7% in Q4 2023.
- How has BioSig Technologies, Inc.'s free cash flow margin changed year-over-year?
- BioSig Technologies, Inc.'s free cash flow margin decreased by 1171.2% year-over-year, from -7,647.9% to -97,216.7%.
- What is the long-term trend for BioSig Technologies, Inc.'s free cash flow margin?
- Over 2 years (2021 to 2023), BioSig Technologies, Inc.'s free cash flow margin has grown at a 298.9% compound annual growth rate (CAGR), from -6,109.1% to -97,216.7%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.